Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03017781 · ClinicalTrials.gov registry record

A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder

A clinical trial of Bipolar Disorder, sponsored by Janssen Research & Development.

Completed
Registry status
224
Enrollment target
20
Study locations

NCT03017781: Completed study of Bipolar Disorder, sponsored by Janssen Research & Development.

NCT03017781 is a study of Bipolar Disorder that has completed, run by Janssen Research & Development. The registered enrollment target is 224 participants, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (32% lower). The trial reports 20 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03017781, a study of Bipolar Disorder, has completed, sponsored by Janssen Research & Development.

COMPLETED
Registry status
224 participants
Enrollment target
20
Study locations

Study Summary

The primary purpose of this study is to compare, over 24 months, the time spent with clinically significant mood symptoms (ie, mania, depression), as measured by the Longitudinal Interval Follow-Up Evaluation (LIFE) and the Psychiatric Status Rating Scale (PSR), in offspring of bipolar parents with and without at least mild impairment in psychosocial functioning.

Primary Outcome

The LIFE is a semi-structured interview developed for prospectively following the course of psychiatric disorders; the LIFE collects detailed psychosocial, psychopathologic and treatment information for a 6-month follow-up interval.

Conditions Studied

Study Locations (20)

California

  • - Culver City
  • - Lemon Grove
  • - Los Angeles
  • - Palo Alto
  • - Panorama City

Ohio

  • - Cincinnati
  • - Cleveland
  • - Columbus

Texas

  • - Austin
  • - Dallas
  • - El Paso

New York

  • - Glen Oaks
  • - Rochester

Florida

  • - Tampa

Indiana

  • - Indianapolis

Maryland

  • - Baltimore

Massachusetts

  • - Boston

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2016-10-25
Est. Completion 2021-04-30
Janssen Research & Development

593 total trials

What the finished NCT03017781 record still lists

NCT03017781 is an observational study that tracks outcomes without assigning an intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (32% lower).

The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT03017781 names 20 study sites across 11 states, led by California, Ohio, Texas.

Frequently Asked Questions

What is clinical trial NCT03017781 about?

NCT03017781 is a clinical study titled "A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder". The primary purpose of this study is to compare, over 24 months, the time spent with clinically significant mood symptoms (ie, mania, depression), as measured by the Longitudinal Interval Follow-Up Evaluation (LIFE) and the Psychiatric Status Rating Scale (PSR), in offspring of bipolar parents with ...

What is the current status of trial NCT03017781?

This trial is currently completed. The enrollment target is 224 participants. The study started on 2016-10-25. Estimated completion is 2021-04-30.

What conditions does trial NCT03017781 study?

This clinical trial studies the following conditions: Bipolar Disorder.

Who is sponsoring clinical trial NCT03017781?

This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03017781 being conducted?

This trial has 20 study locations across California, Florida, Indiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bipolar Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03017781's enrollment target sits among peer trials

224 31st of 162 higher than 131 of 162 other Bipolar Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Bipolar Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04140344 · 224 participants · NA

    The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03017781, the US trial registry maintained by the National Library of Medicine. NCT03017781 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.